IVD Registration in Malaysia: How It Differs from Medical Devices
In vitro diagnostic devices (“IVD”) are regulated by the Medical Device Authority under the Medical Device Act 2012, the same as general medical devices. But they have their own classification system, their own rules, and their own guidelines for assessing risk. Applying general medical device analysis to an IVD is the most common reason a submission is returned.
This guide sets out what is different and where foreign manufacturers get caught.
What counts as an IVD
IVD medical devices are more than test kits. Reagents, calibrators, control materials, specimen receptacles, analysers and the software that interprets results can all fall within the scope depending on its intended purpose.
The intended purpose is important, as a product’s classification follows what the manufacturer says it is for, not what it physically is.
The different classification
IVD classification asks a different question entirely: what is the consequence of a wrong result?
An incorrect result on a pregnancy test and an incorrect result on an HIV screening assay carry very different consequences for an individual and for public health. The classification system is built around that distinction, and it assesses both individual risk and public health risk together.
Malaysia’s IVD classification system is set out in MDA guidance document MDA/GD/0001, which follows the Global Harmonization Task Force (GHTF) harmonized approach. It applies to any product falling within the IVD definition in MDA/GD/0006.
The four risk classes
| Class | Risk profile | Illustrative examples |
| A | Low individual and low public health risk | General laboratory reagents, specimen receptacles, prepared general-purpose culture media |
| B | Moderate individual risk, low public health risk | Self-testing devices for pregnancy and fertility, cholesterol tests, urine test strips |
| C | High individual risk and/or moderate public health risk | Clinical chemistry analyzers, prepared selective culture media, blood glucose self-testing, PSA screening, rubella testing |
| D | High individual risk and high public health risk | Tests detecting HIV, HCV, HBV or HTLV; blood grouping for transfusion; tests for bacterial contamination of blood components |
Kindly be informed that the examples above are illustrative. Classification must be worked through by applying the rules to your specific product and its intended purpose.
Seven rules, applied in order
Two of the rules cause more confusion than the rest.
Self-testing changes the answer. Any IVD intended by the manufacturer for use by a lay person is treated differently from the equivalent professional-use product. A test performed by a trained laboratory technician and the same test sold for home use are not the same regulatory proposition, because the risk of misuse and misinterpretation sits with an untrained user.
Rule 6 is the default. Any IVD not captured by Rules 1 through 5 falls to Class B. Manufacturers who work through the high-risk rules, find none applies, and conclude their product is Class A are frequently wrong — the residual class is B.
The registration route
A local Authorized Representative is mandatory. A foreign manufacturer cannot register an IVD in Malaysia directly. The registration is submitted by, and held in the name of, a Malaysian Authorized Representative holding a valid establishment license.
Conformity assessment is proportional to class. Higher-risk IVDs require assessment by a registered Conformity Assessment Body before registration. MDA Circular Letter No. 2/2014 provides a simplified route where a device has already been approved in a country whose regulatory system MDA recognizes, which can materially shorten the path for products already cleared in the EU, US, Japan, Australia or Canada.
Submission is through MeDC@St. The same online system used for general devices.
Grouping applies. Related products may be submitted together under recognized grouping categories, including test kits and IVD clusters, harmonized with the ASEAN Medical Device Directive. Grouping correctly can significantly reduce the number of separate registrations, and reducing the total fee.
Where foreign manufacturers come unstuck
Applying general device classification logic. Invasiveness and duration of contact are the wrong questions for an IVD.
Defaulting to Class A. Rule 6 puts anything unclassified into Class B.
Overlooking the self-testing rule. Repositioning a professional product for consumer use changes its class.
Treating an existing approval as sufficient. A CE mark or FDA clearance supports the conformity assessment route; but it does not replace Malaysian registration.
Leaving the Authorised Representative decision until last. The AR holds the registration. Appointing whichever distributor offers first is a decision with long consequences, see our guidance on changing your Authorised Representative.
Ignoring grouping. Registering twelve related reagents individually when they qualify as a cluster is an avoidable cost.
Frequently asked questions
Are IVDs regulated by MDA or NPRA in Malaysia?
IVDs are regulated by the Medical Device Authority, under the Medical Device Act 2012.
Do IVDs use the same classification as other medical devices? They use the same letters, from A to D, but the classification of classes are based on a separate rules-based system built on the consequence of an incorrect result rather than on invasiveness.
Can a foreign manufacturer register an IVD directly?
No. A Malaysian Authorised Representative holding a valid establishment licence must hold the registration.
Does an existing CE mark or FDA clearance help?
Yes, through the recognised-country conformity assessment route, but Malaysian registration is still required.
What class is a self-test kit?
It depends on the analyte, but intended use by a lay person is itself a classification factor and generally raises the class relative to the professional equivalent.
Conclusion
The IVD framework in Malaysia is not harder than the general device framework, but it is genuinely separate. The classification rules, the risk logic and the documentation all differ, and the failure mode is nearly always the same: a manufacturer classifying an IVD as though it were a general device, then discovering the error after submission.
Working the classification through correctly at the outset costs a few hours. Getting it wrong costs a submission cycle.
Registering a diagnostic product in Malaysia?
DuoGate acts as an independent Authorized Representative and license holder for foreign IVD and medical device manufacturers. We handle IVD classification, conformity assessment routing, MeDC@St submission, grouping strategy, establishment licensing and post-market obligations without holding any distribution interest in your product.
Contact us to discuss your diagnostic portfolio.
